BMC pregnancy and childbirth · 2025
The assessing of clinical relevance of chromosomal microarray analysis in the prenatal diagnosis of fetal growth restriction.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Peng, Wu Wenli, Zhang Xiaoyun, Li Yuting, Liu Miao, Wang Yanping, Man Dongmei, Wang Fengge
Аннотация
OBJECTIVE: Chromosomal variations are known to play a role in the etiology of fetal growth restriction (FGR). Here, we intend to investigate the significance of Chromosomal Microarray Analysis (CMA) in the prenatal diagnosis of definite FGR.
METHOD: 182 pregnant women with FGR participated in our study, undergoing CMA to identify chromosomal abnormalities. The cohort was categorized into isolated FGR, FGR with ultrasound soft marker abnormalities, and FGR associated with structural malformations.
RESULTS: The detection rates of PCNVs in FGR with structural anomalies are significantly higher than those in the isolated FGR group and the FGR group with abnormal ultrasound soft markers (19.0% vs. 2.1%, 19% vs. 1.5%; χ²=9.33, p = 0.005). Compared to FGR with a single system malformation, the diagnostic rate of chromosomal variations in FGR with multiple system malformations is markedly increased (60% vs. 6.3%; p = 0.028). Advanced maternal age, early-onset FGR, and severe FGR do not appear to influence the diagnostic rate of chromosomal variations (p > 0.05).
CONCLUSION: Chromosomal variations pose a significant risk in FGR with structural abnormalities, associated with the number of organ systems involved. Notably, advanced maternal age, early-onset FGR, and severe FGR do not affect the diagnostic rate of chromosomal variations in FGR.
METHOD: 182 pregnant women with FGR participated in our study, undergoing CMA to identify chromosomal abnormalities. The cohort was categorized into isolated FGR, FGR with ultrasound soft marker abnormalities, and FGR associated with structural malformations.
RESULTS: The detection rates of PCNVs in FGR with structural anomalies are significantly higher than those in the isolated FGR group and the FGR group with abnormal ultrasound soft markers (19.0% vs. 2.1%, 19% vs. 1.5%; χ²=9.33, p = 0.005). Compared to FGR with a single system malformation, the diagnostic rate of chromosomal variations in FGR with multiple system malformations is markedly increased (60% vs. 6.3%; p = 0.028). Advanced maternal age, early-onset FGR, and severe FGR do not appear to influence the diagnostic rate of chromosomal variations (p > 0.05).
CONCLUSION: Chromosomal variations pose a significant risk in FGR with structural abnormalities, associated with the number of organ systems involved. Notably, advanced maternal age, early-onset FGR, and severe FGR do not affect the diagnostic rate of chromosomal variations in FGR.